Home
Howard W. Robin, President & CEO: Nektar Therapeutics NKTR Sell · Filed 06/18
Trade details
- Type
- Insider sale
- Amount
- $277,425
- Shares · price
- 4,500 sh · $61.65 a share
- Held after
- 55,045 sh
- Trade date
- 26/06/17
- Filed
- 26/06/18
- Days to filing
- 1 days
Sold 7.6% of holdings
- Share of holding sold
- 7.6%
Nektar Therapeutics trades, last 26 weeks
What else happened in Nektar Therapeutics around then
Filed or reported within 30 days of the trade day · 05/18~07/17Howard W. Robin's recent trades
- Howard W. Robin
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$30.1K
418 sh
$30.1K
Filed 08/18
Traded 08/18
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$334.5K
5,500 sh
$334.5K
Filed 06/18
Traded 06/17
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$318K
5,303 sh
$318K
Filed 06/18
Traded 06/16
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$285.2K
4,697 sh
$285.2K
Filed 06/18
Traded 06/16
- Howard W. Robin
Planned sale10b5-1 planNektar Therapeutics
Planned sale10b5-1 planNektar Therapeutics
NKTR
$602.7K
10,000 sh
$602.7K
Filed 06/17
Traded 06/17